Status:
UNKNOWN
Fasting and Postprandial Cerebral Blood Flow in Type 2 Diabetic Patients
Lead Sponsor:
Qianfoshan Hospital
Conditions:
Type 2 Diabetes Mellitus
Cerebral Blood Flow
Eligibility:
All Genders
25-65 years
Brief Summary
The purpose of this study is to explore the changes of fasting and postprandial cerebral blood flow in patients with type 2 diabetes mellitus. Some studies have proved that non-fasting blood glucose c...
Detailed Description
In China, due to the aging population and the increase in obesity, the incidence of diabetes is on the rise. Diabetes is the main independent risk factor for cerebrovascular diseases, especially ische...
Eligibility Criteria
Inclusion
- Trial group
- Study time: June 1, 2021, to January 1, 2022;
- Study site: The First Affiliated Hospital of Shandong First Medical University;
- 25-65 years old (including upper and lower limits), male or female;
- Meeting the diagnostic criteria of type 2 diabetes (according to 1997 WHO's diagnostic criteria for type 2 diabetes);
- Fasting blood glucose \< 10 mmol/L;
- HbA1c ≤ 11.0%.
- Control group
- Study time: June 1, 2021, to January 1, 2022;
- Study site: The First Affiliated Hospital of Shandong First Medical University;
- Relatively healthy people without type 2 diabetes mellitus diagnosis;
- Participants whose sex and age and BMI matched with the experimental group.
Exclusion
- Trial group and Control group
- Participants with diabetic retinopathy;
- Participants with diabetic neuropathy;
- Participants with diabetic nephropathy;
- Participants have unilateral or bilateral carotid plaque;
- Participants have a history of cardio-cerebrovascular disease;
- Participants have a history of respiratory disease;
- Participants complicated with hypertension;
- Participants complicated with hyperlipidemia;
- Participants have a smoking history (including previous smoking history);
- Participants complicated with malignant tumor.
- Participants are currently taking anticoagulants or vasodilators;
- Participants do not sign a written informed consent form.
Key Trial Info
Start Date :
July 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2022
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT04897815
Start Date
July 1 2021
End Date
January 1 2022
Last Update
June 16 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.